Trial Profile
Post Marketing Surveillance Study For Observing Safety And Efficacy Of Lyrica.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jan 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Epilepsy; Fibromyalgia; Neuropathic pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 28 Apr 2011 Actual end date (April 2011) added as reported by ClinicalTrials.gov.
- 28 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Nov 2010 Actual initiation date (Jul 2006) added as reported by ClinicalTrials.gov.